GRAIL, Inc. Other Noncash Income (Expense)
GRAIL, Inc. (GRAL) reported Other Noncash Income (Expense) of $259.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06
- GRAIL, Inc. other noncash income (expense) for the quarter ending 2026-06-30 was -$125.00K.
- GRAIL, Inc. other noncash income (expense) for the quarter ending 2026-03-31 was $384.00K.
- GRAIL, Inc. other noncash income (expense) for the quarter ending 2025-12-31 was $23.00K, a 96.58% decline year-over-year.
- GRAIL, Inc. other noncash income (expense) for the quarter ending 2025-09-30 was -$276.00K.
- GRAIL, Inc. other noncash income (expense) for fiscal 2025 was -$1.35M.
- GRAIL, Inc. other noncash income (expense) for fiscal 2024 was -$276.00K.
- GRAIL, Inc. other noncash income (expense) for fiscal 2023 was -$2.83M.
- GRAIL, Inc. other noncash income (expense) for fiscal 2023 was -$1.40M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $259.00K 10-Q · filed 2026-08-06 | $282.00K derived: sum of 3 quarters · filed 2026-08-06 | $6.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $384.00K 10-Q · filed 2026-05-07 | $407.00K derived: sum of 2 quarters · filed 2026-05-07 | $131.00K derived: sum of 3 quarters · filed 2026-05-07 | -$479.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$253.00K derived: sum of 2 quarters · filed 2026-03-12 | -$863.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.35M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$886.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.37M 10-Q · filed 2025-11-13 | -$697.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$610.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.09M 10-Q · filed 2026-08-06 | -$421.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$484.00K 10-Q · filed 2026-05-07 | $189.00K derived: sum of 2 quarters · filed 2026-05-07 | -$399.00K derived: sum of 3 quarters · filed 2026-05-07 | -$707.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $85.00K derived: sum of 2 quarters · filed 2026-03-12 | -$223.00K derived: sum of 3 quarters · filed 2026-03-12 | -$276.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$588.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$896.00K derived: sum of 2 quarters · filed 2025-11-13 | -$949.00K 10-Q · filed 2025-11-13 | -$1.74M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$308.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$361.00K 10-Q · filed 2025-08-13 | -$1.15M derived: sum of 3 quarters · filed 2026-03-12 | -$3.36M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$53.00K 10-Q · filed 2025-05-14 | -$843.00K derived: sum of 2 quarters · filed 2026-03-12 | -$3.05M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | -$790.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$3.00M derived: sum of 2 quarters · filed 2026-03-12 | -$2.83M 10-K · filed 2025-03-05 | |
| 2023-10-01 | -$2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$2.04M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $172.00K 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | -$1.40M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |